NCLAT: Consideration of Debt Restructuring by Lenders Doesn’t Bar Member from Initiating Proceedings  ||  Delhi High Court: In Matters of Medical Evaluation, Courts Should Exercise Restraint  ||  Delhi HC: Any Person in India Has Right to Legally Import Goods from Abroad and Sell the Same  ||  Delhi HC: Waiver to Section 12(5) of Arbitration Act to be Given Once Tribunal is Constituted  ||  Supreme Court Has Asked States to Regularise Existing Court Managers  ||  SC: Union & States to Create Special POSCO Courts on Top Priority  ||  SC Upholds Authority of CERC to Award Compensation for Delays  ||  SC: Arbitral Tribunal Has Discretion to Include in Sum Awarded, Interest at Rate as it Deems Reasonab  ||  SC: Cannot Use Article 142 to Frame Guidelines on Judicial Recusal  ||  SC: Satisfaction Recorder in One EP Won’t Affect Subsequent EPs for Future Breaches    

Delhi HC Enquires on Government Policy on Administration of Amphotericin-B Drug - (04 Jun 2021)

CIVIL

Delhi High Court has directed the Centre to spell out its policy with regard to the priority of patients who should be administered the Amphotericin-B drug, to maximize the lives that could be saved, amongst patients suffering from Mucormycosis also known as black fungus, observing that younger patients may have to be prioritized in comparison with the older generation.

Tags : DELHI HIGH COURT   ADMINISTRATION OF AMPHOTERICIN-B DRUG  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved